Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
KIORA PHARMACEUTICALS INC | Chief Development Officer | Common Stock | 18.6K | $338K | $3.83 | Jul 1, 2024 | Direct |
KIORA PHARMACEUTICALS INC | Chief Development Officer | Stock Option (right to buy) | 14.7K | Jul 1, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
KPRX | KIORA PHARMACEUTICALS INC | Jul 1, 2024 | 2 | $0 | 4 | Jul 3, 2024 | Chief Development Officer |
KPRX | KIORA PHARMACEUTICALS INC | Jun 14, 2024 | 1 | $7.57K | 4 | Jun 14, 2024 | Chief Development Officer |
KPRX | KIORA PHARMACEUTICALS INC | Sep 29, 2023 | 2 | $0 | 4 | Oct 3, 2023 | Chief Development Officer |
KPRX | KIORA PHARMACEUTICALS INC | Mar 3, 2023 | 2 | $0 | 4 | Mar 7, 2023 | Chief Development Officer |
KPRX | KIORA PHARMACEUTICALS INC | Oct 21, 2022 | 2 | $0 | 4 | Oct 25, 2022 | Chief Development Officer |
KPRX | KIORA PHARMACEUTICALS INC | Feb 1, 2022 | 1 | $0 | 4 | Feb 3, 2022 | Chief Development Officer |
KPRX | KIORA PHARMACEUTICALS INC | Oct 21, 2021 | 1 | $0 | 4/A | Nov 22, 2021 | Chief Development Officer |
KPRX | KIORA PHARMACEUTICALS INC | Oct 21, 2021 | 0 | $0 | 3 | Nov 10, 2021 | Chief Development Officer |